Myriad Genetics Inc (MYGN)
Sector • Healthcare Industry • In Vitro & In Vivo Diagnostic Substances |
Industry • In Vitro & In Vivo Diagnostic Substances |
Sector • Healthcare |
News
Breaking Barriers: Unleashing the Potential of MRD Monitoring across Varied Cancer Landscapes
Myriad Genetics Expands Precision Medicine Portfolio: Unlocking New Avenues with Recent Acquisition
Loss Despite revenue elevation at the Myriad Genetics Inc in the most recent fiscal period
Myriad Genetics Inc*s Revenue Rises, but Deficit Widens: Investors Sound the Alarm